J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giannini, C.
Right arrow Articles by Zignego, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giannini, C.
Right arrow Articles by Zignego, A. L.
Agricola
Right arrow Articles by Giannini, C.
Right arrow Articles by Zignego, A. L.
Journal of General Virology (2002), 83, 1665-1671.
© 2002 Society for General Microbiology


Animal: RNA Viruses

Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways

Carlo Giannini1,2, Patrizio Caini1, Francesca Giannelli1, Francesca Fontana2, Dina Kremsdorf2, Christian Bréchot2 and Anna Linda Zignego1

Department of Internal Medicine, University of Florence, Florence, Italy1
INSERM Unit 370, Liver Cancer and Molecular Virology, Pasteur-Necker Institutes, 156 rue de Vaugirard, 75730 Paris, France2

Author for correspondence: Christian Bréchot. Fax +33 1 40615581. e-mail Brechot{at}necker.fr

Hepatitis C virus (HCV) chronic infection has been associated with many lymphoproliferative disorders. Several studies performed on hepatoma and fibroblast cell lines suggest a role of the HCV core protein in activation of cellular transduction pathways that lead to cell proliferation and inhibition of apoptosis. However, no data are available concerning the effects of HCV core expression on B-lymphocyte proliferation and apoptosis. B-lymphocyte cell lines permanently expressing full-length HCV 1b core sequences isolated from chronically infected patients were established using B-cell lines at different degrees of differentiation. Clones and pools of clones permanently expressing the HCV core were selected and characterized for protein expression by Western blot and FACS. Expression of HCV core proteins did not significantly enhance cell proliferation rates under normal culture conditions or under mitogenic stimulation. Analysis of NF-{kappa}B, CRE, TRE and SRE pathways by luciferase reporter genes did not show a significant influence of HCV core expression on these signal transduction cascades in B-lymphocytes. The effects of HCV core on anti-IgM and anti-FAS-induced apoptosis in B-cell lines was also analysed. In this experimental model, HCV core expression did not significantly modify the apoptotic profile of the B-lymphocyte cell lines tested. These data underline a cell type-specific effect of HCV core expression. In fact, it was not possible to show a significant contribution of the HCV core protein in activation of the major B-cell signal transduction pathways involved in the regulation of proliferation and programmed cell death, which is in contrast with the results reported in hepatoma cell lines.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
P. Bare, I. Massud, C. Parodi, L. Belmonte, G. Garcia, M. C. Nebel, M. Corti, M. T. Pinto, R. P. Bianco, M. M. Bracco, et al.
Continuous release of hepatitis C virus (HCV) by peripheral blood mononuclear cells and B-lymphoblastoid cell-line cultures derived from HCV-infected patients
J. Gen. Virol., June 1, 2005; 86(6): 1717 - 1727.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Toubi, A. Kessel, R. Peri, Z. Shmuel, E. Bamberger, E. Sabo, and E. Zuckerman
Enhanced Apoptosis of Peripheral CD5-Negative B Lymphocytes from Chronically Hepatitis C Virus-Infected Patients: Reversal after Antiviral Treatment
J. Virol., October 15, 2004; 78(20): 11379 - 11384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2002 by the Society for General Microbiology.